Category
Ruxolitinib
CAS Number
2102675-40-9
Molecular Formula
C17H19N5O2
Molecular Weight
325.4 g/mol
Synonym

(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanoic acid; 1H-Pyrazole-1-propanoic acid, beta-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-,(betaR)

Keywords
Impurities
Metabolites.
Pharmaceutical Standards
Intermediates
Fine Chemicals
slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Ruxolitinib acid impurity is a degradation or by-product of Ruxolitinib that contains a carboxylic acid group. It is typically monitored in pharmaceutical quality control to ensure the purity and safety of Ruxolitinib-containing drugs, as impurities can affect efficacy and stability.